- ►annals.org K Lin, R Lipsitz, T Miller, S Janakiraman - Annals of Internal Medicine, 2008 - Am Coll Physicians Background: Prostate cancer is the most common nonskin cancer in men in the
United States, and prostate cancer screening has increased in recent years. In
2002, the US Preventive Services Task Force concluded that evidence was ... Cited by 27 - Related articles - All 7 versions
K Lin, R Lipsitz, T Miller, S Janakiraman - Ann Intern Med, 2008 - ahrq.hhs.gov Background: Prostate cancer is the most common nonskin cancer in men in the
United States, and prostate cancer screening has increased in recent years. In
2002, the US Preventive Services Task Force concluded that evidence was ... Related articles - View as HTML - All 5 versions
DJ Hernandez, M Han, EB Humphreys, LA … - Prostate - urology.med.nyu.edu Prostate cancer was detected in 394 (35.6%) men, and 155 (14.0%) had Gleason
≥7 disease. For cancer prediction, the area under the ROC curve (AUC) for the
risk calculator was 66.7%, statistically greater than the AUC for PSA level ... Cited by 3 - Related articles - View as HTML - All 4 versions
LS Lim, K Sherin - American Journal of Preventive Medicine, 2008 - Elsevier Prostate cancer is the leading cancer in US men, and the third leading cause of
cancer deaths. Principal screening tests for detection of asymptomatic prostate
cancer include digital rectal examination (DRE) and measurement of the ... Cited by 15 - Related articles - All 14 versions
S Kawakami, N Numao, Y Okubo, F Koga, S … - European Urology, 2008 - Elsevier Initial extended biopsy (median 22 cores) was performed in 1509 Japanese men
including 1083 at Tokyo Medical and Dental University Hospital (TMDU) and 426 at
Cancer Institute Hospital (CIH). Logistic regression-based nomograms 1 and ... Cited by 12 - Related articles - All 20 versions
- ►alphamedpress.org S Loeb, WJ Catalona - The oncologist, 2008 - ncbi.nlm.nih.gov For more than a decade, prostate-specific antigen (PSA) has been used for
prostate cancer screening. Over the years, this screening has been continually
refined, including investigation into the use of lower total PSA ... Cited by 17 - Related articles - BL Direct - All 8 versions
JM Harrington, EG Jones, T Badger - Oncology Nursing Forum, 2009 - Onc Nurs Society The treatment options for prostate cancer (based on the stage or extent of the
cancer, the age of the man, and his associated comorbidities) are surgery,
radiation therapy, androgen-deprivation (hormonal) therapy (ADT), and ... Cited by 2 - Related articles - All 2 versions
JB Lattouf, F Saad - Current Opinion in Supportive and Palliative Care, 2007 - journals.lww.com Recent findings: Patients with prostate cancer are often osteopenic at baseline.
Implementing androgen-deprivation therapy further increases bone mineral density
loss. Lifestyle changes, vitamin D and calcium supplementation may slow the ... Cited by 2 - Related articles - All 4 versions
M Soleimani, SY Hosseini, M Aliasgari, F … - Scandinavian Journal of Urology and Nephrology, 2009 - informahealthcare.com Objective. The occurrence of erectile dysfunction (ED) in patients who have
undergone prostatectomy has been assessed in the previous studies; however, its
rate and risk factors vary in different studies. This study was conducted ... Cited by 2 - Related articles - All 3 versions
ON Gofrit, AL Shalhav - Harefuah, 2008 - ncbi.nlm.nih.gov Prostate cancer is the most common malignant disease in men. The incidence of
prostate cancer has been rising since the early 1990s. Not all men inflicted by
prostate cancer will develop clinical disease. Therefore, sorting these ... Cited by 2 - Related articles
